Handelsbanken Fonder AB - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 170 filers reported holding CARDLYTICS INC in Q3 2021. The put-call ratio across all filers is 2.31 and the average weighting 0.6%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of CARDLYTICS INC
ValueSharesWeighting
Q1 2022$330,000
-16.9%
6,0000.0%0.00%0.0%
Q4 2021$397,000
-15.5%
6,000
+7.1%
0.00%0.0%
Q3 2021$470,000
-33.9%
5,6000.0%0.00%
-50.0%
Q2 2021$711,000
+24.7%
5,600
+7.7%
0.00%
+33.3%
Q1 2021$570,000
-23.2%
5,2000.0%0.00%
-40.0%
Q4 2020$742,000
+102.2%
5,2000.0%0.01%
+66.7%
Q3 2020$367,0005,2000.00%
Other shareholders
CARDLYTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
CAS Investment Partners, LLC 5,416,116$89,365,91411.46%
KPS Global Asset Management UK Ltd 1,218,830$20,110,69510.97%
WORLDLY PARTNERS MANAGEMENT, LLC 996,881$16,448,53710.50%
General Equity Holdings LP 476,215$7,857,5489.59%
BERYLSON CAPITAL PARTNERS, LLC 195,000$3,217,5008.24%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 454,769$7,503,6895.27%
PB INVESTMENT PARTNERS, L.P. 343,061$5,660,5064.83%
VISA INC. 134,914$2,226,0812.50%
683 Capital Management, LLC 1,760,070$29,041,1562.26%
Antipodean Advisors LLC 20,000$330,0001.69%
View complete list of CARDLYTICS INC shareholders